Improving the survival of PDAC patients requires a detailed understanding of underlying molecular signatures that impact disease progression and treatment response. Recent work published by our group identifies 4 distinct subtypes of PDAC through proteomic analysis of clinical samples with longitudinal clinical metadata. We are looking for a talented and motivated Post Doc to identify and validate molecular drivers of pancreatic cancer subtype differentiation using multiomics and molecular biology techniques.
Ph.D. or equivalent degree in cancer cell biology, biochemistry, molecular biology, analytical chemistry of computational biology.
Experience in mass spectrometry, cell culture, molecular biology and biochemistry desirable.
A vital enterprise in the nation’s heartland, the University of Nebraska Medical Center has its eye on improving the future of health care in Nebraska and beyond. As Nebraska’s only public academic health sciences center, UNMC is committed to the education of a 21st century health care work force, to finding cures and treatments for devastating diseases, to providing the best care for patients, and to serving our state and its communities through award-winning outreach. UNMC also is committed to embracing the richness of diversity, and is a major economic engine for the state of Nebraska. Led by Chancellor Jeffrey P. Gold, M.D., UNMC has six colleges, two institutes and a graduate studies program, serving nearly 4,000 students in more than two dozen programs. Our physician assistant program was recently ranked ninth in the nation by U.S. News & World Report, and our primary care program was ranked 17. The university’s physical therapy, pharmacy and public health programs also are ranked among the top in the country.
Read more about how this public academic health sciences center helps Nebraska.